Results 131 to 140 of about 14,945 (175)

Assessing Efficacy of Interleukin-1 Blockade in Patients with Alcoholic Hepatitis: A Comprehensive Systematic Review of Emerging Evidence. [PDF]

Life (Basel)
Rath S, Girgis M, Gupta I, Chauhan A, Ud Din Z, Hotchandani H, Hasan A, Ahmed R, Qureshi R.   +8 more
europepmc   +1 more source

Long-term follow-up after discontinuation of anti-IL1 treatment in colchicine-resistant familial Mediterranean fever. [PDF]

Rheumatology (Oxford)
Cam V, Bayindir Y, Bilginer Y, Ozen S.
europepmc   +1 more source

Anti-inflammatory pharmacotherapy in patients with cardiovascular disease. [PDF]

Eur Heart J Cardiovasc Pharmacother
Finocchiaro S, Mazzone PM, Ammirabile N, Bordonaro C, Cusmano C, Cutore L, Di Leo G, Faro DC, Giacoppo D, Greco A, Imbesi A, Mauro MS, Raffo C, Spagnolo M, Capodanno D.   +14 more
europepmc   +1 more source

Canakinumab therapy in patients with Familial Mediterranean Fever [PDF]

, 2015
A Hacioglu, E Seyahi, FN Akkoc, G Hatemi, H Ozcan, H Ozdogan, S Ugurlu   +6 more
core   +2 more sources

Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria. [PDF]

Arthritis Rheumatol
Erkens RGA, Rogani G, Huber L, Verwoerd A, Schonenberg-Meinema D, van den Berg JM, Armbrust W, Legger GE, Kamphuis S, Schatorjé EJH, Hoppenreijs EPAH, Swart JF, Jansen MHA, van Loosdregt J, Vastert SJ.   +14 more
europepmc   +1 more source

Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
He D, Li Y, Jiang Z, Cao X, Luo R.
europepmc   +1 more source

Case Report: Mevalonate kinase deficiency: an underdiagnosed cause of ischemic stroke-characterization of a novel genetic variant. [PDF]

Front Immunol
Hamidi LN, Drda JC, Belhocine M, Elfassy HL, Ducharme-Bénard S, Chayer-Lanthier M, Sultana B, Lanthier S.   +7 more
europepmc   +1 more source

PW03-006 - IL-1-B inhibition in Schnitzler’s syndrome [PDF]

, 2013

core   +1 more source

From Bench to Clinic: Advances in Anti-Inflammatory Therapies for Atherosclerotic Coronary Artery Disease. [PDF]

FASEB J
Wang K, Yin Z, Zhang Y, Wu X, Fan L.
europepmc   +1 more source

PCSK9 antagonists and inflammation [PDF]

, 2018
Corsini, Alberto, Ferri, Nicola, Ruscica, Massimiliano, Sirtori, Cesare R.   +3 more
core   +1 more source